Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/2003
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091542 Tissue engineering; wound healing agents; culture product
05/15/2003US20030091518 Mixture containing plant extracts and oils
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2474196A1 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466425A1 Photodynamic therapy for the treatment of hair loss
05/15/2003CA2466232A1 Systems for delivery and release of angiotensin-(1-7)
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466145A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2465894A1 Method for treating or preventing inflammatory diseases
05/15/2003CA2465756A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
05/15/2003CA2465711A1 Aminopyrimidines and pyridines
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464614A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
05/15/2003CA2461183A1 Use of tyrosine kinase inhibitors for whitening human skin and treating melanocyte dysfunction associated diseases
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310511A2 Oligopeptides for promoting hair growth
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310262A1 Topical composition having undifferentiated plant seed cells and method for using same
05/14/2003EP1310261A1 Use of the extract of Vigna aconitifolia in a cosmetic and/or dermopharmaceutical composition
05/14/2003EP1310256A2 Use of prostaglandin A or its derivatives for the treatment of psoriasis
05/14/2003EP1310255A1 Antipruritic agent
05/14/2003EP1310251A1 Antipruritic agent
05/14/2003EP1310241A2 Skin treatment using a retinoid
05/14/2003EP1309721A2 Modulating multiple lineage kinase proteins
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309532A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
05/14/2003EP1309374A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309352A1 Antifungal ketoconazole composition for topical use
05/14/2003EP1309351A1 Dermatological formulation
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1309309A1 Dermatological composition
05/14/2003EP1240162B1 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1109790B1 1, 2, 4-triazole-3-thione compounds
05/14/2003EP1102746B1 Substituted phenylamidines with antithrombotic action
05/14/2003EP1041996A4 Keratinocyte growth factor-2 formulations
05/14/2003EP0934313B1 N-substituted azaheterocyclic compounds
05/14/2003EP0797427B1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
05/14/2003CN1418254A Method for remodelling cell wall polysaccharide structures in plants
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418104A Cosmetic use of hop and ornithine
05/14/2003CN1418103A Polysaccharidic esters of N-derivatives of glutamic acid
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418087A Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light
05/14/2003CN1418083A Use of plant extracts and sugars to protect keratinous tissue
05/14/2003CN1416890A Alopecia-treating liniment and its prepn
05/14/2003CN1416886A Skin care ointment and its prepn
05/14/2003CN1416882A Burn treating Chinese medicine liquid and its prepn
05/14/2003CN1416878A Mastoproliferation treating medicine
05/14/2003CN1416875A 17-hydroxy C27 steroid compound and its synthesis and use
05/14/2003CN1416863A External medicine for treating dermatosis
05/14/2003CN1416859A Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process
05/14/2003CN1416840A Alopecia treating tincture and its prepn
05/14/2003CN1416819A Tincture for treating psoriasis and its prepn
05/14/2003CN1416806A Local composition with undifferentiated plant seed cell and ifs usage
05/14/2003CN1108167C Shuangtian oil
05/13/2003US6562995 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters are disclosed. The novel compounds have two carbonyl groups connected by a linking moiety having
05/13/2003US6562988 16-HETE (16-hydroxyeicosatetraenoic acid) analogues such as the methanesulfonamide ester (-CO-NH-SO2-CH3); inhibiting neutrophil adhesion and neutrophil aggregation; treating stroke, inflammatory diseases
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562795 Motilide compounds
05/13/2003US6562794 Cosmetic and dermatological formulations comprising flavonoids
1 ... 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 ... 1065